NCT02595073View on ClinicalTrials.gov

Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

September 4, 2015

Primary Completion Date

January 17, 2017

Study Completion Date

August 29, 2017

Conditions
Atopic Dermatitis
Interventions
DRUG

DSXS

Active treatment

DRUG

Placebo

Placebo treatment

Trial Locations (1)

10532

Taro Pharmaceuticals USA Inc., Hawthorne

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT02595073 - Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis | Biotech Hunter | Biotech Hunter